Table 3 CO-verified smoking cessation outcomes
Outcome | Snus, n = 158 (%) | Placebo, n = 161 (%) | Odds ratio (snus vs placebo) | 95% C.I. | P |
|---|---|---|---|---|---|
Point-prevalence cessation (1 week): | |||||
-week 12 | 2 (1.3) | 0 | - | - | - |
-week 24 | 9 (5.7) | 3 (1.9) | 3.4 | 0.9-12.8 | 0.08 |
-week 36 | 15 (9.5) | 6 (3.7) | 2.7 | 1.0-7.3 | 0.04 |
-week 48 | 25 (15.8) | 15 (9.3) | 1.9 | 0.9-3.7 | 0.08 |
Continued cessation at week 36: | |||||
-4 weeks | 13 (8.2) | 6 (3.7) | 2.3 | 0.9-6.4 | 0.10 |
-12 weeks | 9 (5.7) | 3 (1.9) | 3.3 | 0.9-12.5 | 0.08 |
-24 weeks | 2 (1.3) | 0 | - | - | - |
Continued cessation at week 48: | |||||
-4 weeks | 22 (13.9) | 12 (7.5) | 2.1 | 1.0-4.4 | 0.06 |
-12 weeks | 15 (9.5) | 6 (3.7) | 2.7 | 1.0-7.3 | 0.04 |
-24 weeks | 9 (5.7) | 3 (1.9) | 3.3 | 0.9-12.5 | 0.08 |